HIV-positive TB patients on ART (antiretroviral therapy) in Western Pacific (WHO region)
Western Pacific (WHO region): HIV-positive TB patients on ART (antiretroviral therapy) was 68.0% in 2024. ▲ Rising
HIV-positive TB patients on ART (antiretroviral therapy) in Western Pacific (WHO region), 2003–2024
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for hiv-positive tb patients on art (antiretroviral therapy) in Western Pacific (WHO region) is 68.0%, measured in 2024.
The figure is up 21.4% on the previous year and up 11.5% over ten years.
Over the whole period, hiv-positive tb patients on art (antiretroviral therapy) in Western Pacific (WHO region) peaked at 100.0% in 2003 and was at its lowest, 14.0%, in 2007.
The long-run direction has been consistently rising across the 22 years of available data.
HIV-positive TB patients on ART (antiretroviral therapy) in Western Pacific (WHO region), year by year
| Year | Value | Change |
|---|---|---|
| 2003 | 100.0% | — |
| 2004 | 49.0% | -51.0% |
| 2005 | 57.0% | +16.3% |
| 2006 | 29.0% | -49.1% |
| 2007 | 14.0% | -51.7% |
| 2008 | 28.0% | +100.0% |
| 2009 | 16.0% | -42.9% |
| 2010 | 40.0% | +150.0% |
| 2011 | 46.0% | +15.0% |
| 2012 | 55.0% | +19.6% |
| 2013 | 59.0% | +7.3% |
| 2014 | 61.0% | +3.4% |
| 2015 | 48.0% | -21.3% |
| 2016 | 67.0% | +39.6% |
| 2017 | 58.0% | -13.4% |
| 2018 | 69.0% | +19.0% |
| 2019 | 65.0% | -5.8% |
| 2020 | 64.0% | -1.5% |
| 2021 | 65.0% | +1.6% |
| 2022 | 50.0% | -23.1% |
| 2023 | 56.0% | +12.0% |
| 2024 | 68.0% | +21.4% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 41.9% | 14.0% | 100.0% | 7 |
| 2010s | 56.8% | 40.0% | 69.0% | 10 |
| 2020s | 60.6% | 50.0% | 68.0% | 5 |
More health data for Western Pacific (WHO region)
- Pertussis - number of reported cases, gaps filled 159,013 (2025)
- Total tetanus - number of reported cases, gaps filled 5,464 (2025)
- Neonatal tetanus - number of reported cases, gaps filled 214 (2025)
- Measles - number of reported cases, gaps filled 78,782 (2025)
- Diphtheria - number of reported cases, gaps filled 428 (2025)
- Number of under-five deaths, annual growth rate -5.73 % change on previous year (2024)
- Number of neonatal deaths, annual growth rate -4.28 % change on previous year (2024)
- Number of infant deaths, annual growth rate -4.75 % change on previous year (2024)
- Measles - number of reported cases, annual growth rate 228.55 % change on previous year (2025)
- Pertussis - number of reported cases, annual growth rate -73.21 % change on previous year (2025)
Frequently asked questions
- What is hiv-positive tb patients on art (antiretroviral therapy) in Western Pacific (WHO region)?
- Hiv-positive tb patients on art (antiretroviral therapy) in Western Pacific (WHO region) was 68.0% in 2024, according to World Health Organization, Global Health Observatory.
- What is the highest hiv-positive tb patients on art (antiretroviral therapy) recorded in Western Pacific (WHO region)?
- The highest recorded value was 100.0% in 2003.
- What is the lowest hiv-positive tb patients on art (antiretroviral therapy) recorded in Western Pacific (WHO region)?
- The lowest recorded value was 14.0% in 2007.
- How does Western Pacific (WHO region) rank for hiv-positive tb patients on art (antiretroviral therapy)?
- Western Pacific (WHO region) ranks 10th out of 11 groups with data for 2024.
- Is hiv-positive tb patients on art (antiretroviral therapy) rising or falling in Western Pacific (WHO region)?
- Over the last ten years it is up 11.5%. The long-run trend across the full record is rising.
- Where does this Western Pacific (WHO region) data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 22 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).